Takeda Pharmaceutical Co Ltd (TKPHF) — 6-K Filings

6-K Filings (50)

• 6-K Filing — Dec 18, 2025
• Takeda Pharma Files 6-K Report — Dec 8, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on December 8, 2025, reporting as a foreign private issuer. The filing indicates Takeda will file its ann
• Takeda Pharma Files 6-K, Reports as Foreign Issuer — Nov 28, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on November 28, 2025, reporting as a foreign private issuer. The filing indicates Takeda will file its an
• Takeda Pharma Files 6-K Report — Oct 30, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on October 30, 2025, reporting as a foreign private issuer. The filing indicates Takeda will file its ann
• Takeda Pharma Files 6-K for October 2025 Reporting — Oct 1, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on October 1, 2025, reporting as a foreign private issuer. The filing indicates Takeda will file its annu
• Takeda Pharma Files 6-K Report — Sep 25, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on September 25, 2025, reporting its status as a foreign private issuer. The filing indicates that Takeda
• Takeda Pharmaceutical Files 6-K for September 2025 — Sep 8, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on September 8, 2025, reporting information for the month of September 2025. The filing indicates Takeda
• Takeda Pharmaceutical Files 6-K Report — Jul 31, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 31, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharma Files 6-K, Confirms 20-F Reporting — Jul 30, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 30, 2025, reporting its status as a foreign private issuer. The filing indicates that Takeda will
• Takeda Pharmaceutical Files 6-K Report — Jul 14, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 14, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharmaceutical Files 6-K Report — Jul 9, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 9, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executive
• Takeda Pharmaceutical Files 6-K Report — Jul 8, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 8, 2025, reporting as a foreign private issuer. The filing indicates Takeda will file its annual
• Takeda Pharmaceutical Files 6-K for New Indenture — Jul 2, 2025 Risk: low
  On July 2, 2025, Takeda Pharmaceutical Company Limited filed a Form 6-K to report an Indenture dated as of July 2, 2025. This indenture involves Takeda Pharmace
• Takeda Pharmaceutical Files 6-K Report — Jul 1, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 1, 2025, reporting information as of July 2025. The filing indicates Takeda is a foreign private
• Takeda Pharma Files June 2025 6-K Report — Jun 30, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 30, 2025, reporting information as a foreign private issuer for the month of June 2025. The filin
• Takeda Pharma Files 6-K for June 2025 — Jun 25, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 25, 2025, reporting as a foreign private issuer. The filing is for the month of June 2025 and ind
• Takeda Pharma Files 6-K Report — Jun 12, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 12, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Files 6-K Report for June 2025 — Jun 10, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 10, 2025, reporting as a foreign private issuer. The filing is for the month of June 2025 and ind
• Takeda Pharmaceutical Files June 2025 6-K Report — Jun 6, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 6, 2025, reporting as a foreign private issuer. The filing indicates Takeda is submitting its rep
• Takeda Files 6-K Report for June 2025 — Jun 2, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 2, 2025, reporting as a foreign private issuer for the month of June 2025. The filing indicates T
• Takeda Pharmaceutical Files Routine 6-K Report — May 28, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on May 28, 2025, reporting its activities for the month of May 2025. This filing is a routine report for
• Takeda Files 6-K Report for May 2025 — May 14, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on May 14, 2025, reporting information as a foreign private issuer. The filing is for the month of May 20
• Takeda Pharmaceutical Files 6-K Report — May 8, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on May 8, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executive
• Takeda Pharmaceutical Files April 2025 6-K Report — Apr 22, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on April 22, 2025, reporting as a foreign private issuer. The filing is for the month of April 2025 and i
• Takeda Pharmaceutical Files 6-K Report — Apr 14, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on April 14, 2025, reporting as a foreign private issuer. The filing is for the month of April 2025 and i
• Takeda Pharma Files 6-K, Confirms 20-F Reporting — Apr 1, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on April 1, 2025, reporting its status as a foreign private issuer. The filing indicates that Takeda will
• Takeda Pharmaceutical Files 6-K for March 2025 — Mar 26, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on March 26, 2025, reporting as a foreign private issuer for the month of March 2025. The filing indicate
• Takeda Pharmaceutical Files 6-K Report — Mar 13, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on March 13, 2025, reporting as a foreign private issuer for the month of March 2025. The filing confirms
• Takeda Pharmaceutical Files Routine 6-K Disclosure — Mar 3, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on March 3, 2025, reporting as a foreign private issuer. The filing does not contain specific financial f
• Takeda Pharmaceutical Files 6-K Report — Jan 30, 2025 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on January 30, 2025, reporting as a foreign private issuer. The filing indicates Takeda is submitting its
• Takeda Pharmaceutical Files 6-K for December 2024 — Dec 18, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on December 18, 2024, reporting its status as a foreign private issuer. The filing indicates that Takeda
• Takeda Pharmaceutical Files 6-K Report — Dec 13, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on December 13, 2024, reporting information as of December 2024. The filing is for a foreign private issu
• Takeda Pharmaceutical Files 6-K for December 2024 — Dec 2, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on December 2, 2024, reporting as a foreign private issuer for the month of December 2024. The filing ind
• Takeda Pharma Files 6-K, Confirms 20-F Reporting — Oct 31, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on October 31, 2024, reporting its status as a foreign private issuer. The filing indicates that Takeda w
• Takeda Pharmaceutical Files 6-K for September 2024 — Sep 26, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on September 26, 2024, to report information as a foreign private issuer for the month of September 2024.
• Takeda Pharmaceutical Files 6-K — Jul 31, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 31, 2024, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharmaceutical Files 6-K Report — Jul 10, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 10, 2024, reporting information as a foreign private issuer. The filing indicates Takeda's princi
• Takeda Pharmaceutical Files 6-K — Jul 9, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 9, 2024, reporting information as a foreign private issuer. The filing indicates Takeda's princip
• Takeda Pharma Files Forms for $3 Billion in New Senior Notes — Jul 5, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 5, 2024, to report the forms of several senior notes. These include $1.1 billion in 5.300% Senior
• Takeda Pharmaceutical Files 6-K Report — Jul 2, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 2, 2024, to report information as a foreign private issuer for the month of July 2024. The filing
• Takeda Pharmaceutical Files July 2024 6-K Report — Jul 1, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on July 1, 2024, reporting information for the month of July 2024. The filing indicates Takeda is a forei
• Takeda Pharmaceutical Files 6-K — Jun 26, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 26, 2024, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharmaceutical Files 6-K Report — Jun 17, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 17, 2024, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharma Files 6-K for June 2024 — Jun 11, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 11, 2024, to report information as a foreign private issuer for the month of June 2024. The filin
• Takeda Pharmaceutical Files 6-K Report — Jun 10, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 10, 2024, reporting as a foreign private issuer. The filing indicates Takeda's principal executiv
• Takeda Pharmaceutical Files 6-K Report — Jun 7, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 7, 2024, to report information as a foreign private issuer. The filing indicates Takeda's princip
• Takeda Pharmaceutical Files June 2024 6-K Report — Jun 3, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on June 3, 2024, reporting information for the month of June 2024. The filing indicates Takeda is a forei
• Takeda Pharmaceutical Files 6-K Report — May 29, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on May 29, 2024, reporting its status as a foreign private issuer. The filing indicates Takeda's principa
• Takeda Pharmaceutical Files 6-K Report — May 21, 2024 Risk: low
  Takeda Pharmaceutical Company Limited filed a Form 6-K on May 21, 2024, to report information as a foreign private issuer. The filing indicates Takeda's princip
• Takeda Pharma Files 6-K, Confirms 20-F Filing — May 9, 2024 Risk: low
  Takeda Pharmaceutical Co. Ltd. filed a Form 6-K on May 9, 2024, reporting as a foreign private issuer. The filing indicates Takeda's principal executive offices

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX